These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29703731)

  • 1. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.
    Stockstill K; Doyle TM; Yan X; Chen Z; Janes K; Little JW; Braden K; Lauro F; Giancotti LA; Harada CM; Yadav R; Xiao WH; Lionberger JM; Neumann WL; Bennett GJ; Weng HR; Spiegel S; Salvemini D
    J Exp Med; 2018 May; 215(5):1301-1313. PubMed ID: 29703731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
    Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
    J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.
    Chen Z; Doyle TM; Luongo L; Largent-Milnes TM; Giancotti LA; Kolar G; Squillace S; Boccella S; Walker JK; Pendleton A; Spiegel S; Neumann WL; Vanderah TW; Salvemini D
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10557-10562. PubMed ID: 31068460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
    Stockstill K; Wahlman C; Braden K; Chen Z; Yosten GL; Tosh DK; Jacobson KA; Doyle TM; Samson WK; Salvemini D
    Pain; 2020 Jan; 161(1):177-184. PubMed ID: 31490328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.
    Grenald SA; Doyle TM; Zhang H; Slosky LM; Chen Z; Largent-Milnes TM; Spiegel S; Vanderah TW; Salvemini D
    Pain; 2017 Sep; 158(9):1733-1742. PubMed ID: 28570482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P
    Pondelick AM; Moncayo LV; Donvito G; McLane VD; Gillespie JC; Hauser KF; Spiegel S; Lichtman AH; Sim-Selley LJ; Selley DE
    Neuropharmacology; 2024 Dec; 261():110165. PubMed ID: 39303855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
    Singh SK; Spiegel S
    Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation.
    Sim-Selley LJ; Wilkerson JL; Burston JJ; Hauser KF; McLane V; Welch SP; Lichtman AH; Selley DE
    J Pharmacol Exp Ther; 2018 Sep; 366(3):509-518. PubMed ID: 29945931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord.
    Xie JD; Chen SR; Chen H; Pan HL
    Neuropharmacology; 2017 Sep; 123():477-487. PubMed ID: 28663117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
    Doolen S; Iannitti T; Donahue RR; Shaw BC; Grachen CM; Taylor BK
    Pain; 2018 Feb; 159(2):224-238. PubMed ID: 29140922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
    Li C; Li JN; Kays J; Guerrero M; Nicol GD
    J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Sphingosine-1-Phosphate Receptor 1 in the Spinal Cord Produces Mechanohypersensitivity Through the Activation of Inflammasome and IL-1β Pathway.
    Doyle TM; Chen Z; Durante M; Salvemini D
    J Pain; 2019 Aug; 20(8):956-964. PubMed ID: 30802544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720/Fingolimod mitigates paclitaxel-induced Sparcl1-driven neuropathic pain and breast cancer progression.
    Singh SK; Weigel C; Brown RDR; Green CD; Tuck C; Salvemini D; Spiegel S
    FASEB J; 2024 Aug; 38(15):e23872. PubMed ID: 39126272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaining on Pain.
    Emery EC; Wood JN
    N Engl J Med; 2018 Aug; 379(5):485-487. PubMed ID: 30067934
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
    Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
    Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
    Doyle TM; Hutchinson MR; Braden K; Janes K; Staikopoulos V; Chen Z; Neumann WL; Spiegel S; Salvemini D
    J Neuroinflammation; 2020 Oct; 17(1):314. PubMed ID: 33092620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.
    Cartwright TA; Campos CR; Cannon RE; Miller DS
    J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking SphK/S1P/S1PR1 axis signaling pathway alleviates remifentanil-induced hyperalgesia in rats.
    Li J; Wang Q; Gao Y; Ma W; Sun Z; Yu Y; Li Y; Li Q; Wang C
    Neurosci Lett; 2023 Mar; 801():137131. PubMed ID: 36801239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment.
    Squillace S; Niehoff ML; Doyle TM; Green M; Esposito E; Cuzzocrea S; Arnatt CK; Spiegel S; Farr SA; Salvemini D
    J Clin Invest; 2022 Sep; 132(17):. PubMed ID: 36047496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
    Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
    Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.